IATR Stock Overview
Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 1/6 |
Athens Medical C.S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.58 |
| 52 Week High | €2.15 |
| 52 Week Low | €1.38 |
| Beta | 1.16 |
| 1 Month Change | -11.98% |
| 3 Month Change | -12.95% |
| 1 Year Change | 2.27% |
| 3 Year Change | 3.61% |
| 5 Year Change | -7.06% |
| Change since IPO | -9.23% |
Recent News & Updates
Recent updates
Athens Medical C.S.A (ATH:IATR) Seems To Be Using A Lot Of Debt
Jun 09
There Are Reasons To Feel Uneasy About Athens Medical C.S.A's (ATH:IATR) Returns On Capital
May 09Athens Medical C.S.A (ATH:IATR) Is Reinvesting At Lower Rates Of Return
Jan 05Athens Medical C.S.A (ATH:IATR) Seems To Use Debt Quite Sensibly
Oct 04There's Been No Shortage Of Growth Recently For Athens Medical C.S.A's (ATH:IATR) Returns On Capital
Aug 12There May Be Reason For Hope In Athens Medical C.S.A's (ATH:IATR) Disappointing Earnings
May 07Can Athens Medical C.S.A (ATH:IATR) Continue To Grow Its Returns On Capital?
Mar 10Did Athens Medical Center's (ATH:IATR) Share Price Deserve to Gain 92%?
Feb 02Do Insiders Own Lots Of Shares In Athens Medical Center S.A. (ATH:IATR)?
Dec 27What Can The Trends At Athens Medical Center (ATH:IATR) Tell Us About Their Returns?
Nov 30
Shareholder Returns
| IATR | GR Healthcare | GR Market | |
|---|---|---|---|
| 7D | -6.2% | 1.9% | -2.6% |
| 1Y | 2.3% | -6.2% | 22.4% |
Return vs Industry: IATR exceeded the Greek Healthcare industry which returned -7.7% over the past year.
Return vs Market: IATR underperformed the Greek Market which returned 20.6% over the past year.
Price Volatility
| IATR volatility | |
|---|---|
| IATR Average Weekly Movement | 3.8% |
| Healthcare Industry Average Movement | 5.1% |
| Market Average Movement | 3.9% |
| 10% most volatile stocks in GR Market | 8.1% |
| 10% least volatile stocks in GR Market | 2.4% |
Stable Share Price: IATR has not had significant price volatility in the past 3 months.
Volatility Over Time: IATR's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 3,230 | Vasilios Apostolopoulos | www.iatriko.gr |
Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for prostate bladder, kidney, and testicular cancer, as well as interventional cardiology, interventional electrophysiology, and pediatric cardiology; cardiac surgery; robotic surgery, including general, gynecologic, and urology services; and neuro- and spine surgery services. It also provides medical services for range of orthopedics, such as foot and ankle, hand and wrist, hip, knee, shoulder, and spine; sports injuries; plastic Surgeries for face, body, breast, obesity, reconstructive plastic surgery, scar correction, and sex reassignment; bariatric surgery for gastric banding, sleeve gastrectomy, and biliopancreatic diversion with duodenal switch; and chronic diseases, including diabetes, endocrinology, heat failure, high blood pressure, pain management, respiratory system, stroke, and thyroid conditions.
Athens Medical C.S.A. Fundamentals Summary
| IATR fundamental statistics | |
|---|---|
| Market cap | €137.04m |
| Earnings (TTM) | €9.07m |
| Revenue (TTM) | €249.37m |
15.1x
P/E Ratio0.5x
P/S RatioIs IATR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IATR income statement (TTM) | |
|---|---|
| Revenue | €249.37m |
| Cost of Revenue | €185.18m |
| Gross Profit | €64.19m |
| Other Expenses | €55.12m |
| Earnings | €9.07m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Apr 30, 2024
| Earnings per share (EPS) | 0.10 |
| Gross Margin | 25.74% |
| Net Profit Margin | 3.64% |
| Debt/Equity Ratio | 124.8% |
How did IATR perform over the long term?
See historical performance and comparison